AG
CNTA

Artal Group’s Centessa Pharmaceuticals CNTA Stock Holding History

Artal Group’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,112,500
Closed -$19.1M – 19
2024
Q2 		$19.1M Buy
2,112,500
+700,000
+50% +$6.32M 0.49% 25
2024
Q1 		$16M Buy
1,412,500
+400,000
+40% +$4.52M 0.41% 31
2023
Q4 		$8.06M Buy
+1,012,500
New +$8.06M 0.27% 37